CRSP

CRISPR THERAPEUTICS AG

CRSP·H17182108·US·Common Stock·Healthcare - Biotechnology-13D/G

CRSP (CRISPR THERAPEUTICS AG) is held by 174 institutional investors as of Q2 2026. Largest holders: ARK Investment Management LLC ($516M), BlackRock, Inc. ($455.4M), Orbis Allan Gray Ltd ($297.2M). Net institutional sentiment: Mixed.

174
Holders
(18 Elite)
$3.4B
Total Value
56% (179)
Consensus
101 buying - 78 selling
13F: Insider & Congress: Updated regularly
CRSP

Smart Money Verdict

View all
Loading verdict
Held by 174 funds
18 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Mar 24, 2026 · Activists Aug 14, 2026 · Congress none

ActivistOIORBIS INVESTMENT MANAGEMENT LTD5.6%Aug 14, 2026
ActivistBlackRock, Inc.BlackRock, Inc.8.3%Jul 27, 2026
ActivistOIORBIS INVESTMENT MANAGEMENT LTD6.3%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
9.5M(-16.4%)$516M3.4%-6.83%
0
Increased
8.3M(+8.7%)$455.4M0.0%+24.08%
34
Decreased
5.4M(-10.8%)$297.2M1.0%+13.27%
0
Increased
4.7M(+0.5%)$259M0.0%+2.05%
31
Increased
4.3M(+8.5%)$235.7M0.0%+5.48%
33
Increased
2.5M(+5.6%)$136.9M0.0%+8.69%
32
Increased
2M(+34.1%)$108.5M0.1%+11.58%
39
Decreased
1.9M(-2.4%)$104.1M0.0%+51.23%
0
Decreased
1.7M(-7.2%)$93.8M0.1%-7.57%
0
Decreased
1.7M(-7.2%)$93.8M1.2%+4.63%
0
Decreased
1.3M(-25.3%)$71.9M0.0%+29.94%
0
Increased
1.3M(+6.9%)$69.2M0.0%-11.19%
32
Increased
1.2M(+3.4%)$64.5M0.0%+2.22%
31
Increased
1.2M(+17.5%)$63M0.0%+43.88%
34
Increased
1.1M(+1.8%)$57.7M0.0%+0.25%
30
New
893,812$48.7M0.0%+8.60%
41
Increased
879,949(+31.7%)$48M0.0%+6.01%
37
Increased
863,091(+7.6%)$47.1M0.0%+13.78%
32
Increased
648,713(+18.6%)$35.4M0.0%+3.00%
34
Increased
570,040(+5.0%)$31.1M0.0%+2.31%
30

Showing 1-20 of 182

1 / 10
CRSPCRSPCRISPR THERAPEUTICS AG

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used